Mycoplasma Testing Market 2020: Technology, Solution, Components, Emerging Trends, Key Segments, Size & Share, Regional Growth Analysis till 2025 - PowerPoint PPT Presentation

About This Presentation

Mycoplasma Testing Market 2020: Technology, Solution, Components, Emerging Trends, Key Segments, Size & Share, Regional Growth Analysis till 2025


Adroit Market Research has announced the addition of the “Mycoplasma Testing Market” report to their offering. – PowerPoint PPT presentation

Number of Views:41
Slides: 8
Provided by: Thomashinds


Transcript and Presenter's Notes

Title: Mycoplasma Testing Market 2020: Technology, Solution, Components, Emerging Trends, Key Segments, Size & Share, Regional Growth Analysis till 2025

Global Mycoplasma Testing Market
  • by Product (Instruments, Kits Reagents,
    Services), Technology (PCR, ELISA, Direct Assay,
    Indirect Assay, Microbial Culture Techniques,
    Enzymatic Methods), Application (Cell Line
    Testing, Virus Testing, End of Production Cells
    Testing, Others), End-Use (Cell Banks, Contract
    Research Organizations, Pharmaceutical
    Biotechnology Companies, Others), Region and
    Forecast, 2018 to 2028

Single Use License US 4400
Request Sample
Global Mycoplasma Testing Market Size, Share
Industry Forecast 2020-2028
  • The mycoplasma contamination is a significant
    problem for all pharma biotech firms as it will
    lead to human diseases and interact with cell
    culture. In culture, mycoplasma generally alters
    the replication of mammalian cells and other
    cellular processes that typically lead to a
    decrease in the production of recombinant
    proteins. Checking for mycoplasma infection in
    the processing of substrates for cell culture is
    also important. Contamination of mycoplasma
    typically originates from products of cell
    culture, such as serum, or an infected operator.
  • Different government agencies are gradually
    funding research programs in the pharmaceutical
    and biotechnology fields. For example, to promote
    research-based efforts for new drug production,
    the U.S. government extends financial assistance
    to multinational pharmaceutical firms. The FDA in
    April 2019 stated its decision to change the
    regulations for the single research form used for
    mycoplasma detection.
  • According to the department, the legislation is
    stringent in nature and therefore prohibits the
    use of other types of research that could have
    the ability to diagnose mycoplasma reliably.
    These developments in the regulation of biologics
    are supposed to increase the sensitivity and
    accuracy of mycoplasma detection tests, and new
    methods are emerging. The growth in federal
    support for pharmaceutical and biotechnology
    research has also accelerated RD operations,
    fostering the tremendous application of
    mycoplasma testing.

Global Mycoplasma Testing Market Size, Share
Industry Forecast 2020-2028
  • Owing to massive investments in RD activities by
    pharma biotech firms, the segment accounted for
    the highest market share in 2019. These
    industries are involved in raw material quality
    controls, thereby ensuring biological safety
    management. Also, due to an increase in the
    prevalence of diseases such as rheumatoid
    arthritis and psoriasis, the biopharmaceutical
    industry is growing.
  • The global mycoplasma testing market is
    categorized based on the product, technology,
    application, and end-use. Region-wise, North
    America mycoplasma testing accounted for the
    majority of the market share in 2019. However,
    due to the substantial awareness and funding
    initiatives developed by countries such as India,
    Asia Pacific is projected to be the
    fastest-growing region by 2028. Different
    developmental measures are being pursued by the
    Indian Government to promote additional RD
    programs to launch new medicines. Also, in the
    near term, regulatory measures implemented by
    healthcare organizations favoring changes in the
    efficiency of biosafety are projected to expand
    growth opportunities.
  • Browse the complete report on _at_

Key segments of the global mycoplasma testing
  • Product Overview, 2018-2028 (USD Million)
  • Instruments
  • Kits Reagents
  • Services
  • Technology Overview, 2018-2028 (USD Million)
  • PCR
  • Direct Assay
  • Indirect Assay
  • Microbial Culture Techniques
  • Enzymatic Methods
  • Application Overview, 2018-2028 (USD Million)
  • Cell Line Testing
  • Virus Testing
  • End of Production Cells Testing
  • Others

Key segments of the global mycoplasma testing
  • Regional Overview, 2018-2028 (USD Million)
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East Africa
  • Important Companies in Global Mycoplasma Testing
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Lonza
  • PromoCell GmbH
  • American Type Culture Collection
  • Charles River Laboratories International, Inc.
  • Bionique Testing Laboratories, Inc.
  • Biological Industries Israel Beit Haemek Ltd.
  • InvivoGen
  • Eurofins Scientific

Global Mycoplasma Testing Market Size, Share
Industry Forecast 2020-2028
  • Reasons for the study
  • The purpose of the study is to give an exhaustive
    outlook of the global Mycoplasma Testing industry
  • The overall segmentation of Mycoplasma Testing
    market, especially key segments are thoroughly
  • Presence of major players and their wide product
    portfolio across developed countries is
    anticipated to further boost the growth of
    Mycoplasma Testing market
  • Who should buy this report?
  • The report on the global mycoplasma testing
    market is suitable for all the players across the
    value chain including raw material suppliers,
    Mycoplasma Testing providers, pharmaceutical and
    medical device manufacturers, distributors,
    suppliers and retailers
  • Venture capitalists and investors looking for
    more information on the future outlook of the
    global mycoplasma testing market
  • Consultants, analysts, researchers, and
    academicians looking for insights shaping the
    global mycoplasma testing market
  • Purchase a single user copy of the global
    Mycoplasma Testing Market report_at_

About Us
  • Adroit Market Research is an India-based business
    analytics and consulting company. Our target
    audience is a wide range of corporations,
    manufacturing companies, product/technology
    development institutions and industry
    associations that require understanding of a
    markets size, key trends, participants and
    future outlook of an industry. We intend to
    become our clients knowledge partner and provide
    them with valuable market insights to help create
    opportunities that increase their revenues. We
    follow a code Explore, Learn and Transform. At
    our core, we are curious people who love to
    identify and understand industry patterns, create
    an insightful study around our findings and churn
    out money-making roadmaps. Our analysts have
    tracked high growth markets in chemicals
    materials, healthcare pharmaceuticals,
    semiconductor electronics, energy power, food
    retail, consumer goods, technology, and
    machinery equipment sectors across the world to
    identify new opportunities, potential customers,
    prepare go-to-market (GTM) strategies, identify
    segments for revenue growth for companies, and
    many more.
  • US Headquarters3131 McKinney Ave Ste 600
    Dallas, TX 75204 ,U.S.A 
  • Phone 1 (214) 884-6068
  • Email
Write a Comment
User Comments (0)